This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Colorado. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Kimberly A. Casalvieri: Inventor in Cancer Research
Introduction
Kimberly A. Casalvieri is an inventor associated with Denver, Colorado, and the University of Colorado. Her patent work includes pharmaceutical compounds and methods aimed at inhibiting cancer-related targets and treating cancer.
Latest Patents
Casalvieri’s listed patents include two inventions:
- WEE1 kinase inhibitors and methods of treating cancer using the same. This invention describes compounds, their pharmaceutically acceptable salts or prodrugs, and methods for using them to inhibit WEE1 kinase and treat cancer in a subject.
- Fused bicyclic pyrimidine derivatives and uses thereof. This invention concerns compounds of a specified formula, including stereoisomers, prodrugs, and pharmaceutically acceptable salts, as well as uses of those compounds.
Career Highlights
Casalvieri is associated with the University of Colorado, where her patent activity reflects research into medicinal chemistry and potential cancer therapies. The supplied information lists 2 patents for her.
Collaborations
Her listed collaborators include Philip Reigan and Donald S. Backos. Their names appear alongside work connected to the development of pharmaceutical compounds and therapeutic approaches.
Conclusion
Kimberly A. Casalvieri’s listed inventions focus on kinase inhibition and fused bicyclic pyrimidine compounds, highlighting her contributions to patent activity related to cancer research and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile